Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study-Reference-Cited by-同舟云学术

Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study

Published:2023-03 Issue: Volume:170 Page:195-202
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Cibula David,Akilli Huseyin,Jarkovsky Jiri,van Lonkhuijzen Luc,Scambia Giovanni,Meydanli Mehmet Mutlu,Ortiz David Isla,Falconer Henrik,Abu-Rustum Nadeem R.,Odetto Diego,Klát Jaroslav,dos Reis Ricardo,Zapardiel Ignacio,Di Martino Giampaolo,Presl Jiri,Laky Rene,López Aldo,Weinberger Vit,Obermair Andreas,Pareja Rene,Poncová Renata,Mom Constantijne,Bizzarri Nicolò,Borčinová Martina,Aslan Koray,Salcedo Hernandez Rosa Angélica,Fons Guus,Benešová Klára,Dostálek Lukáš,Ayhan Ali

Funder

Agentura Pro Zdravotnický Výzkum České Republiky

Univerzita Karlova v Praze

Ministerstvo Zdravotnictví Ceské Republiky

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference21 articles.

1. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer;Cibula;Radiother. Oncol.,2018

2. ESGO survey on current practice in the Management of Cervical Cancer;Dostalek;Int. J. Gynecol. Cancer,2018

3. NCCN Guidelines Version 2.2020,2020